Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma and Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00712790
What this trial is testing

Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Singapore Clinical Research Institute 35
Not applicableUnknownNCT04996459
What this trial is testing

Tislelizumab in the Systematic Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 40
Not applicableNot Yet RecruitingNCT06836518
What this trial is testing

Sialic Acid in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sohag University 100
Testing effectiveness (Phase 2)Looking for participantsNCT07337460
What this trial is testing

Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors

Who this might be right for
Hepatocellular Carcinoma (HCC)
Northern Jiangsu People's Hospital 30
Not applicableNot Yet RecruitingNCT07707661
What this trial is testing

Application of Super-Resolution Ultrasound (SRUS) in Liver Tumor

Who this might be right for
Hepatocellular Carcinoma (HCC)Intrahepatic Cholangiocellular CarcinomaHepatic Hemangioma+2 more
Eastern Hepatobiliary Surgery Hospital 350
Early research (Phase 1)Ended earlyNCT04060342
What this trial is testing

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Not applicableUnknownNCT05458791
What this trial is testing

Intra-arterial Perfusion in Interventional Radiology

Who this might be right for
Hepatocellular Carcinoma
Palo Alto Veterans Institute for Research 20
Testing effectiveness (Phase 2)Looking for participantsNCT06852820
What this trial is testing

68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)

Who this might be right for
Liver CancerHepatocellular CarcinomaMetastatic Liver Cancer
Melissa Lumish 10
Not applicableEnded earlyNCT05718882
What this trial is testing

Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC

Who this might be right for
Liver CancerHepatocellular CarcinomaResistant Cancer
RenJi Hospital 5
Early research (Phase 1)UnknownNCT05675462
What this trial is testing

Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 25
Testing effectiveness (Phase 2)Looking for participantsNCT05440708
What this trial is testing

TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tvardi Therapeutics, Incorporated 193
Testing effectiveness (Phase 2)Looking for participantsNCT05503797
What this trial is testing

Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Who this might be right for
Cancer Harboring BRAF AlterationsHGGLGG+1 more
Fore Biotherapeutics 254
Large-scale testing (Phase 3)UnknownNCT03851913
What this trial is testing

The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Beyond Milan Criteria BCLC Stage A/B Hepatocellular Carcinoma Who Underwent Hepatectomy

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 344
Testing effectiveness (Phase 2)Ended earlyNCT04541173
What this trial is testing

Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Aiwu Ruth He, MD 6
Large-scale testing (Phase 3)Study completedNCT00241020
What this trial is testing

Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Novartis Pharmaceuticals 270
Early research (Phase 1)UnknownNCT05240690
What this trial is testing

Umbilical Cord Blood Derived MAK Immune Cells Combined With Standard Second-Line Treatments for Hepatobiliary and Pancreatic Malignancies

Who this might be right for
Stage IV Pancreatic CancerHepatocellular Carcinoma , Cholangiocarcinoma
Zhou Fuxiang 27
Not applicableUnknownNCT02321579
What this trial is testing

Vitamin B-6 and Glutathione on Inflammation, Homocysteine, Oxidative Stress and Antioxidant Capacities

Who this might be right for
Liver CirrhosisLiver Cancer
Taichung Veterans General Hospital 25
Not applicableActive Not RecruitingNCT06096896
What this trial is testing

The Efficacy and Safety of EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter, Prospective, Observational Study

Who this might be right for
Early Hepatocellular Carcinoma
Shandong Provincial Hospital 334
Not applicableNot Yet RecruitingNCT07667608
What this trial is testing

Ultrasound Assessment of Diaphragmatic Structure and Function in Patients With Liver Cirrhosis: A Point-of-Care Tool for Predicting Complications and Sarcopenia in Limited Resource Settings

Who this might be right for
Cirrhosis of the LiverAscitesPleural Effusion Disorder+3 more
Assiut University 120
Not applicableLooking for participantsNCT06236568
What this trial is testing

Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation

Who this might be right for
Hepatocellular CarcinomaLiver Transplant; Complications
Azienda Ospedaliero-Universitaria di Modena 40
Next Page